Work

Efficacy and safety of enzalutamide (ENZA) in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with abiraterone acetate (Abi): A multicenter, single-arm, open-label study.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.6_suppl.165

Authors: Johann S. De Bono, Simon Chowdhury, Susan Feyerabend, Tony Elliott, Enrique Grande, Amal Melhem-Bertrandt, Benoit Baron, Mohammad Hirmand, Patrick Werbrouck, Karim Fizazi

Institutions: Institute of Cancer Research, St Thomas' Hospital, The Christie Hospital, Hospital Universitario Ramón y Cajal, Astellas Pharma (United States), Astellas Pharma (Netherlands), Medivation, Inc. (United States), AZ Groeninge, Université Paris-Sud, Institut Gustave Roussy

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601659212

Cites:

Cited by: 2

Related to: 10